Innovation Pharmaceuticals Inc (IPIX)

[BioTechMaven]

For those who have direct communication with management I would love to hear the following question answered:

If Prurisol is equivalent to Otezla in safety and efficacy in a powered Phase 2B trial, how is it that you determine a starting valuation at minimum of $1B? Can you please explain your rationale when Otezla earned $1B in revenue in the last two consecutive years.

I'd also welcome that question to the peanut gallery here...